NEW YORK, Oct. 14, 2021 /PRNewswire/ -- As per the latest research based on Zion Market Research study, Point Of Care Testing Market gathered revenue about US$ 31.17 Billion in 2020 and is expected to reach USD 78.85 Billion by 2028, growing at a CAGR of 12.3% from 2021 to 2028.
Point Of Care Testing Market By Product, (Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy & Fertility Testing Products, Fecal Occult Testing Products, Hematology Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Drugs-Of-Abuse Testing Products, Cholesterol Testing Products, Other POC Products) By Platform, (Lateral Flow Assays, Immunoassays, Microfluidics 1, Molecular Diagnostics, Dipsticks) By Mode Of Purchase, (OTC Testing Products, Prescription-Based Testing Products) By End Users (Outpatient & Ambulatory Care Facilities, Hospitals & Critical Care Centers, Home Care Settings 5, Other End Users) - Global Industry Perspective, Comprehensive Analysis And Forecast, 2021-2028.
Point of care (POC) testing devices are mainly used for diagnosis of disease for early detection and monitoring along with its effective treatment and management. During last decades there is a significant growth in the pervasiveness of chronic diseases which has led to upsurge the patient inflow. Point of care test is beneficial in providing the instantaneous results to the patient. However, although there are good opportunities for the growth of the market. To introduce the test and devices into the market the product has to meet the strict government regulations for devices or test. This stringent government regulations and poor reimbursement policies may hinder the growth of the market during the forecasted period. The decentralization of healthcare is one of the major trends observed in patient care now a days which is anticipated to offer new growth opportunities to the overall point of care (POC) testing industry.
COVID-19 is a global public emergency which have led us to serious consequences for all the sectors as it have reduced the growth to a significant level. World is still suffering through COVID-19 outbreak posing social, health, and economic emergency. It's been a year now since the outbreak of COVID-19 hindering the various markets causing the significant loss in the revenue. However, Healthcare sector, research & development activities can be seen to get on track with new inflow of investments.
Point of care (POC) testing devices and research and development activities are some of the severely affected areas of point of care molecular diagnostic market due to COVID-19 outbreak. However, the outbreak of COVID-19 has accelerated the global demand for diagnostic kits to rapidly detect the diseases. Thus, many players are emphasizing on increasing the supply of tests worldwide.
The global Point of care (POC) testing Market is majorly driven by increasing dominance of the infectious diseases, hematological diseases, cancer, and others. Owing to the increase in chronic diseases and the patients suffering from it, healthcare awareness among the people is increasing tremendously which can be the factor responsible for the growth of the Point Of Care Testing Market. Increasing government support and increasing awareness among the people have fueled the growth of the Point of care (POC) testing market. Also, Factors such as the rising number of clinics adopting Point of care (POC) testing for the rapid detection of infectious diseases in the near future are expected to drive market growth during the forecast period.
However, multi-layered regulations set by the FDA and laboratory regulations under CLIA can restrain the growth of Point of care (POC) testing Market.
Based on product, the Point Of Care Testing Market is segmented into, Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy & Fertility Testing Products, Fecal Occult Testing Products, Hematology Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Drugs-of-abuse Testing Products, Cholesterol Testing Products, Other POC Products.
Product Segment is anticipated to help the largest share owing to acceptance of new technologies among researchers and academia technological advancements, large base of population suffering from chronic and acute diseases.
By End Users Segment Analysis
Based on End Users, the Point Of Care Testing Market is segmented into, Outpatient & Ambulatory Care Facilities, Hospitals & Critical Care Centers, Home Care Settings 5, Other End Users.
Owing to increasing in number of end users such as hospitals and clinics, Outpatient & Ambulatory Care Facilities and other end users, and adoption of new technologies, the Point Of Care Testing Market are expected to drive market growth during the forecast period.
North America holds the largest share in the global point of care testing market owing to the huge patient population well developed economy and high healthcare expenditure. Also, north America include the major key players and Supportive government scenarios and higher people awareness of self-testing and home care products and significant adoption of novel technologies can be the responsible factors to increase the market growth.
Asia Pacific is anticipated to be the fastest growing market with double digit CAGR. The presence of huge opportunity for the development of the market and huge population base in this region, are some of the major castors responsible for the growth of point of care testing market in Asia pacific region.
Global Point of Care Testing Market: Competitive Players
Some of the significant players in the global point of care testing market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Becton, Dickinson and Company, Johnson & Johnson, Danaher Corporation, Chembio Diagnostics, Quidel Corporation, EKF Diagnostics, Trinity Biotech, AccuBioTech, Nova Biomedical, PTS Diagnostics, Instrumentation Laboratory Company, and Sekisui Diagnostics.
The Point Of Care Testing Market is segmented as follows:
Glucose Monitoring Products
Cardiometabolic Monitoring Products
Infectious Disease Testing Products
Coagulation Monitoring Products
Pregnancy & Fertility Testing Products
Fecal Occult Testing Products
Hematology Testing Products
Tumor/Cancer Marker Testing Products
Urinalysis Testing Products
Drugs-of-abuse Testing Products
Cholesterol Testing Products
Other POC Products
Lateral Flow Assays
By Mode of Purchase
OTC Testing Products
Prescription-based Testing Products
By End Users
Outpatient & Ambulatory Care Facilities
Hospitals & Critical Care Centers
Home Care Settings 5
Other End Users
Rest of Europe
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Browse Other Related Research Reports from Zion Market Research
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.